Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07789717) titled 'Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA)' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Ilsan Cha hospital
Condition:
Breast Cancer
Aromatase Inhibitor
Aromatase Inhibitor Induced Arthralgia
Intervention:
Procedure: pharmacopuncture therapy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: January 5, 2026
Target Sample Size: 30
Countries of Recruitment:
South Korea
To know more, visit https://clinicaltrials....